NYSEHealth CarePharmaceutical PreparationsALISO VIEJO, CA

AEON Biopharma, Inc. AEON

Ask your AI

Estimated market cap $7.63M49.88M shares, shares as of Aug 6, 2026CIK 1837607

Insider trades, 12 mo

1 buy · 0 sells

$241.5K bought, open market

Congress trades, 24 mo

—

No disclosed trades

13F holders, Q3 2026

15.1% of shares · 2 added

13F holders

…

Lobbying, 12 mo

—

No lobbying filings

Federal contracts, 12 mo

—

None matched

Ask your AI:

Latest 10-Q

Q2 2026

What changed in AEON Biopharma, Inc.'s latest quarterly report, compared with the one before.

Filed Aug 12, 2026 · Quarter ended Jun 30, 2026

Compared with the 10-Q for the quarter ended Mar 31, 2026. Sections compared: management's discussion, risk factors, legal proceedings and controls and procedures.

Read the 10-Q on sec.gov ↗Filing index ↗

Latest 10-Q

What changed in AEON Biopharma, Inc.'s latest quarterly report, compared with the one before.

Loading…

Insider trades

1 in 12 mo

Open-market trades from Form 4. 10b5-1 marks a plan set in advance.

No open-market insider trades reported since Aug 19, 2026. Insiders have two business days to file.

Recent insider trades

Timothy P. Lynch 10% owner	Aug 19 Form 4 ↗	Buy	+$241.5K 1.15M sh @ $0.21	-21.0%
Jost Fischer Director	May 21, 2025 Form 4 ↗	Buy	+$29.4K 60,000 sh @ $0.49	-97.9%
Jost Fischer Director	May 20, 2025 Form 4 ↗	Buy	+$30.6K 60,000 sh @ $0.51	-97.2%
Jost Fischer Director	May 19, 2025 Form 4 ↗	Buy	+$25.0K 50,000 sh @ $0.50	-96.8%

All AEON insider trades →Planned sales (Form 144): see notices

Insider trades

Open-market trades from Form 4. 10b5-1 marks a plan set in advance.

Loading…

13F holders

7.51M shares

18 funds report AEON. Values checked against market prices.

Funds own 26% of shares (Q2 2026)

22 funds hold the stock.

Q3 2026: 15% · 5,560 of ~8,900 funds reported so far

Q2 2025>100%
Q3 202512%
Q4 202521%
Q1 202611%
Q2 202626%
Q3 2026 (so far)15%

Q3 2026. 4 new, 2 added to, 2 trimmed, 8 exited since Q2 2026.

Top 13F holders
#
1	Nantahala Capital Management, LLC 13F ↗	4.40M	$1.3M	New
2	Stonepine Capital Management, LLC 13F ↗	2.13M	$637.7K	New
3	DG Capital Management, LLC 13F ↗	259,146	$77.7K	New
4	Jane Street Group, LLC 13F ↗	249,762	$74.9K	New
5	Vanguard Fiduciary Trust Co 13F ↗	214,725	$64.4K	+1465.8%
6	Geode Capital Management, LLC 13F ↗	95,311	$28.6K	unchanged
7	Vanguard Capital Management LLC 13F ↗	90,529	$27.2K	unchanged
8	Formidable Asset Management, LLC 13F ↗	20,024	$14.4K	unchanged
9	Blue Owl Capital Holdings LP 13F ↗	42,353	$12.7K	unchanged
10	LPL Financial LLC 13F ↗	11,500	$3,450	-0.1%

Download CSV Every fund that holds AEON, not only these ten. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.

13F holders

Funds that report this stock, checked against market prices.

Loading…

Trades by members of Congress

Disclosed in dollar ranges, up to 45 days after the trade.

No recent congressional trades for this company.

Trades by members of Congress

Disclosed in dollar ranges, up to 45 days after the trade.

Loading…

Lobbying

What AEON Biopharma, Inc. and its lobbying firms report each quarter.

No recent lobbying filings for this company.

Lobbying

What AEON Biopharma, Inc. and its lobbying firms report each quarter.

Loading…

Institutional ownership over time

How many funds reported holding the stock at the end of each quarter, and how many shares they held between them.

Funds holding the stock

Shares they report

Funds holding the stock by quarter

Q1 2025	16	—	1.53M	$884.8K
Q2 2025	18	+2	1.27M	$585.7K
Q3 2025	21	+3	1.36M	$1.1M
Q4 2025	22	+1	2.44M	$1.7M
Q1 2026	24	+2	2.84M	$2.8M
Q2 2026	22	-2	12.80M	$9.2M
Q3 2026	18	-4	7.51M	$2.2M

Each point is a quarter-end, from Q1 2025 to Q3 2026. A fund's 13F lists its long positions in US-listed securities as of the last day of the quarter and arrives up to 45 days later, so each point shows holdings at quarter-end, not on the day they were reported.

Common shares only; options and bonds are left out. When a fund amends a report, the amended version is the one counted.

The history follows the company's current CUSIP number (00791X209). If the company's shares were ever re-issued under a different CUSIP, the quarters before the change are not part of this series, so the first point (Q1 2025) can be later than the stock's first appearance in 13F reports.

Share counts are adjusted for stock splits; none took place between these quarters. Values are in dollars as reported at the time and are not adjusted.

A quarter appears once our daily update has built its summary. If a summary cannot be built, older reports are kept and the chart shows the quarters it has until the next update repairs it.

Institutional ownership over time

How many funds reported holding the stock at the end of each quarter, and how many shares they held between them.

Loading…

More filings and data

Each opens the table.

Ownership stakes6 in 12 mo 8-K events3 in 90 days PatentsNone on record Short interestFINRA · updated Oct 15 Planned insider salesNone in 12 mo Executive payNone on record Wikipedia attentionNone on record SEC enforcementNone on record Clinical trials0 active IPO history3 registrations Ownership stakes…8-K events…Patents…Short interest…Planned insider sales…Executive pay…Wikipedia attention…SEC enforcement…

About the company

The basics from the company’s SEC registration.

Legal name: AEON Biopharma, Inc.
Address: 130 VANTIS DRIVE, SUITE 170, ALISO VIEJO, CA 92656
Phone: (949) 354-6499
Fiscal year ends: Dec 31
Filer category: emerging growth company
Incorporated in: DE
Listed as: AEON (NYSE)
Former names: Priveterra Acquisition Corp. (until 2023)
SEC filings: All filings on SEC EDGAR ↗

About the company

The basics from the company’s SEC registration.

Loading…

$0.153−$0.01 (−3.59%) Nov 13 close

1M3M1Y

Oct 13, 2026Low $0.153 · High $0.294Nov 13, 2026

Aug 13, 2026Low $0.153 · High $0.3269Nov 13, 2026

Nov 13, 2025Low $0.153 · High $1.36Nov 13, 2026

Congress purchase Congress sale Insider sale over $1M

Adjusted for stock splits; not for dividends. Where prices come from.

Live chart

Intraday and historical prices from TradingView. Quotes may be delayed.

Loading chart…

Information, not investment advice. Company matching is automatic; check the source before relying on one row.